Synexus Enrolls 87% Of Patients For Osteoporosis Study

The trial involved 11 of Synexus’ 26 dedicated recruitment centres across the UK, Europe and South Africa. There were nine US sites also taking part. Of the 565 patients that were randomised, Synexus recruited 494 over an average of eighteen weeks per site, with the Polish and South African sites recruiting above their targets.

Michael Fort, chief executive at Synexus, said: “Yet again these results show that the Synexus recruitment model is working consistently throughout our sites in the UK, Europe and in South Africa.

“We have quite clearly out-performed recruitment in the US and there is no doubt that this is down to our dedicated recruitment centres being managed and run by professional, full-time investigators who can look after and process the large number of patients that we screen and randomise following the success of our marketing campaigns across the board and our outreach work in parts of Central and Eastern Europe and South Africa.”